Skip to main content

Table 2 Hemodynamic variables

From: Effects of terlipressin infusion during hepatobiliary surgery on systemic and splanchnic haemodynamics, renal function and blood loss: a double-blind, randomized clinical trial

Variables Group T N = 25 Group C N = 25 P value
HR (beat/m.) Baseline 77.3 ± 7.9 80.1 ± 7.7 0.22
Intraoperative 79.6 ± 14.4 84.5 ± 14.5 0.24
Postoperative 85.2 ± 11.3* 90.8 ± 12* 0.09
MAP (mm HG) Baseline 85.8 ± 8.7 89.4 ± 12.8 0.25
Intraoperative 88.7 ± 7.2 83.9 ± 6.98 0.02¥
Postoperative 80.2 ± 12.3 86.1 ± 9.9 0.07
CVP (mm Hg) Baseline 14.0 (8–20) 14.0 (8–22) 0.34
Intraoperative 12.4 (8.3–19.2) 12.6 (7.1–21.4) 0.84
Postoperative 9.0 (2–12)” 8.0 (5–21)” 0.60
CI (L/min/m2) Baseline 3.6 ± 0.9 3.4 ± 1.1 0.43
Intraoperative 3.1 ± 0.3* 3.3 ± 0.6 0.15
SVV % Baseline 7.4 ± 3.90 9.2 ± 2.98 0.08
Intraoperative 10.6 ± 2.17* 11.0 ± 2.14* 0.50
SVR (dyne.s/cm5) Baseline 1030.2 ± 318.1 1021.8 ± 285.2 0.92
Intraoperative 1144.9 ± 221.0* 1007.2 ± 232.4 0.04¥
Need for inotropic support, no. of patients 1(4%) 3(12%) 0.30
Inotropic score 5 (5–5) 10(5–10) 0.32
  1. Data are presented as mean ± SD or median (range). HR heart rate; MAP mean arterial pressure; CI cardiac index; SVV stroke volume variation; SVR systemic vascular resistance. P-value <0.05 was considered statistically significant. (*) significant difference in comparison to the baseline value within the same group. (¥) significant difference between the two groups. The inotropic score is calculated as follows: One point was assigned for each mcg/kg/min of dobutamine, and 1 point was assigned for each 10 ng/kg/min of norepinephrine)